Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Tolerability and Clinical Activity of Novel First-in-Class Oral Agent, Inobrodib (CCS1477), in Combination with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Emma Searle, Victoria Campbell, Charlotte Pawlyn, Ceri Bygrave, Sarah Gooding, James Cavet, Matthew W. Jenner, Vivek Radhakrishnan, Steve Knapper, Dima el-Sharkawi, Jenny O'Nions, Tomasz Knurowski, Karen Clegg, Will Henry West, Debbie Haynes, Kris Frese, Tim Somervaille

Blood (2024) 144 (Supplement 1): 1023.

https://doi.org/10.1182/blood-2024-199779

Published: 2024

Journal Articles

Predictors of Successful Allogeneic Stem Cell Donor Collection

Samar Kulkarni, Adrian Bloor, Mike Dennis, Angie Leather, Rose Brewster, Helen Morgan, Laura Roger, Amy Cadogan, Alethea Braden, Loredana Oraka, Ellen Lidstone, Sarah Wilson, John Murray, Jo Tomlins, Ahmed Abdulgawad, Mohd Mamat, James Cavet, Anna Z Castleton

Blood (2024) 144 (Supplement 1): 7270.

https://doi.org/10.1182/blood-2024-211181

Published: 2024

Journal Articles

Rituximab Responsive Cytopenia Following Allogeneic Stem Cell Transplantation

John Murray, Joanita Kintu, Adrian Bloor, Mike Dennis, Anna Z Castleton, Mark Williams, David Kaye, James Cavet, Samar Kulkarni

Blood (2024) 144 (Supplement 1): 7400.

https://doi.org/10.1182/blood-2024-211445

Published: 2024

Journal Articles

Prediction Model to Evaluate Engraftment Kinetics Following Stem Cell Transplantation

Samar Kulkarni, Adrian Bloor, Mike Dennis, Anna Z Castleton, Mark Williams, Ahmed Abdulgawad, Tim Somervaille, Daniel H Wiseman, Vismay Deshani, Emma Searle, Angie Leather, John Murray, Sally Pickering, James Cavet

Blood (2024) 144 (Supplement 1): 3496.

https://doi.org/10.1182/blood-2024-211021

Published: 2024

Journal Articles

Fungal Blood Stream Infections (BSI) in Hematology-Oncology Patients Have Worse Outcomes Than Solid Tumour Patients

Vismay Deshani, H Hemat, Adrian Bloor, Mike Dennis, Alex Peel, Adam Jeans, Anna Z Castleton, Emma Searle, Daniel H Wiseman, Mark Williams, Richard Chasty, Ahmed Abdulgawad, Tim Somervaille, John Murray, Jane Robertson, James Cavet, Samar Kulkarni

Blood (2024) 144 (Supplement 1): 7897.

https://doi.org/10.1182/blood-2024-198526

Published: 2024

Journal Articles

Tolerability and Clinical Activity of Novel First in Class Oral Agent, Inobrodib (CCS1477), in Combination with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Blood (2023) 142 (Supplement 1): 2005.

https://doi.org/10.1182/blood-2023-174652

Published: 2023

Journal Articles

Potent Pre-Clinical and Early Phase Clinical Activity of EP300/CBP Bromodomain Inhibitor CCS1477 in Multiple Myeloma

Luciano Nicosia, Nigel Brooks, Fabio Amaral, Oliver Sinclair, Neil A Pegg, William West, Tomasz Knurowski, Kris Frese, Karen Clegg, James Cavet, Emma Searle, Tim C.P Somervaille

Blood (2022) 140 (Supplement 1): 852–853.

https://doi.org/10.1182/blood-2022-157535

Published: 2022

Journal Articles

Use of Cryopreserved Allogeneic PBSC Results in Delayed Engraftment and Increased Incidence of Poor Graft Function

Samar Kulkarni, John Murray, James Clarke, Mike Dennis, Amit Patel, Anna Castleton, James Cavet, Angela Leather, Lyndsey Ashton, Diane Sweeney, Joanna Tomlins, Adrian Bloor, Rita Angelica, Mark Williams

Blood (2021) 138 (Supplement 1): 1778.

https://doi.org/10.1182/blood-2021-154199

Published: 2021

Journal Articles

Post Allograft Rituximab Responsive Cytopenia (RRC)

Samar Kulkarni, MD, John Murray, RGN, MSc, David Kaye, MSc, Michael Dennis, FRCPath, Anna Castleton, FRCPath, Mohd K Mamat, MRCP, James Cavet, Daniel Wiseman, FRCPath, Tim Somervaille, FRCPath, Sven Sommerfeld, MRCP, Richard Chasty, FRCPath, Adrian Bloor, FRCPath

Blood (2019) 134 (Supplement_1): 5645.

https://doi.org/10.1182/blood-2019-132214

Published: 2019

Journal Articles

Determinants of Long-Term Survival Following Allogeneic Stem Cell Transplantation for Multiple Myeloma: A Multi-Centre Analysis Across the United Kingdom and Australia

Salvatore Fiorenza, MBBS PhDMPH BSc, David J M Routledge, MSc, PGCert, MRCP, FRCPath, Jenny Collins, BSc, Michael J Shipton, MBChB, BSc, Simon J. Harrison, MBBS,MRCP,FRCPath,FRACP,PhD, James Cavet, Eleni Tholouli, MD PhD, David Ritchie, MD PhD

Blood (2017) 130 (Supplement 1): 4569.

https://doi.org/10.1182/blood.V130.Suppl_1.4569.4569

Published: 2017

Journal Articles

Outcomes with Extracorporeal Photopheresis in the Management of Chronic Gvhd: A Multi-Centre Experience

David Routledge, MSc, BSc (Hons), FRCPath, MRCP, John Murray, BSc (hons), MSc, Fiona Dignan, MD, Amanda Calderwood, Adrian Bloor, Eleni Tholouli, Therese Callaghan, Muhammad Ameer Saif, MD FRCPath, MBBS, MRCP, Michael Dennis, FRCPath, James Cavet, FRCPath, Samar Kulkarni, MD MRCP, FRCPath

Blood (2016) 128 (22): 4595.

https://doi.org/10.1182/blood.V128.22.4595.4595

Published: 2016

Journal Articles

Seattle Regimen RIC-HSCT in Early-Phase Multiple Myeloma: A Multi-Centre Experience Demonstrating Very Low Treatment-Related Mortality and Rapid Graft-Versus-Myeloma Effect Associated with Graft-Versus-Host Disease

Michael J Shipton, MBChB, BSc, David JM Routledge, MRCP, Neil Bodagh, MBChB, BSc, James Cavet, FRCPath, Eleni Tholouli, Samar Kulkarni, FRCPath, Simon DJ Gibbs

Blood (2015) 126 (23): 4355.

https://doi.org/10.1182/blood.V126.23.4355.4355

Published: 2015

Journal Articles

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy and Safety Of Siltuximab, An Anti-Interleukin-6 Monoclonal Antibody, In Patients With Multicentric Castleman’s Disease

Blood (2013) 122 (21): 505.

https://doi.org/10.1182/blood.V122.21.505.505

Published: 2013

Journal Articles

Utility of Second and Subsequent Peripheral Blood Stem Cell (PBSC) Mobilization in Myeloma Patients

Samar Kulkarni, MD, MRCP, FRCPath, Adrian JC Bloor, PhD, FRCP, FRCPath, Mike Dennis, Dianne Sweeney, Rita Angelica, Sarah Grantham, Siobhan Donaghey, Angela Leather, Lyndsey Ashton, James Cavet

Blood (2011) 118 (21): 4401.

https://doi.org/10.1182/blood.V118.21.4401.4401

Published: 2011

Journal Articles

HCT-CI Does Not Reliably Predict Outcome Following Allogeneic Stem Cell Transplant Due to Poor Correlation Between Clinical and Laboratory Assessment of Comorbidities

John Murray, RGN, MSc, Mike Dennis, MD, MRCP, FRCPath, James Cavet, PhD, FRCP, FRCPath, Samar Kulkarni, MD, MRCP, FRCPath, Adrian JC Bloor, PhD, FRCP, FRCPath

Blood (2011) 118 (21): 4562.

https://doi.org/10.1182/blood.V118.21.4562.4562

Published: 2011

Journal Articles

The Role of High Dose Chemotherapy and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma Refractory to Initial Induction Therapy

Christopher Parrish, MA, MB, BChir, MRCP, Amin Rahemtulla, MBBS, PhD, FRCP, James Cavet, BA, MBBS, FRCP(UK), FRCPath, PhD., Rachel Pearce, Kirkland Keiran, MSc, SRN, Julia Lee, Charles Craddock, Keith Wilson, Gordon Cook, MD, PhD, FRCP, (Glas), FRCPath, FRCPI

Blood (2010) 116 (21): 1341.

https://doi.org/10.1182/blood.V116.21.1341.1341

Published: 2010

Journal Articles

Thyroid Function Abnormalities In Adults Following Haematopoetic Stem Cell Transplant (HSCT).

John Murray, RGN, MSc, James Cavet, BA, MBBS, FRCP(UK), FRCPath, PhD., Adrian Bloor, PhD, MRCP, FRCPath, Samar Kulkarni, MD, MRCP, Michael Dennis, FRCP, FRCPath, Malcolm Blower, MSc, Ric Swindell, Georg Brabant, MD, PhD, FRCP

Blood (2010) 116 (21): 1305.

https://doi.org/10.1182/blood.V116.21.1305.1305

Published: 2010

Journal Articles

A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma

Philippe Moreau, Halyna V Pylypenko, Sebastian Grosicki, Evgeniy E Karamanesht, Xavier Leleu, Maria E Grishunina, Grigoriy B Rekhtman, Zvenyslava Masliak, Tadeusz Robak, Anna V Shubina, Jean-Paul Fermand, Martin Kropff, James Cavet, Sudha Parasuraman, Huaibao Feng, Donna M Skee, Helgi van de Velde, William M Deraedt, Jean-Luc Harousseau

Blood (2010) 116 (21): 312.

https://doi.org/10.1182/blood.V116.21.312.312

Published: 2010

Journal Articles

Distal Limb Infiltration by Transformed Lymphoplasmacytoid Lymphoma.

James Cavet, MRCPath, PhD, Daniel Wiseman, MBChB

Blood (2006) 108 (11): 4647.

https://doi.org/10.1182/blood.V108.11.4647.4647

Published: 2006

Journal Articles

Trauma Site Localisation of Extramedullary Plasmacytomata in Thalidomide Treated Myeloma Patients.

James Cavet, MRCPath, PhD, Hamish Hunter, MRCP, Gordon Cook, FRCPath, PhD

Blood (2006) 108 (11): 5069.

https://doi.org/10.1182/blood.V108.11.5069.5069

Published: 2006

NARROW

Tolerability and Clinical Activity of Novel First-in-Class Oral Agent, Inobrodib (CCS1477), in Combination with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Predictors of Successful Allogeneic Stem Cell Donor Collection

Rituximab Responsive Cytopenia Following Allogeneic Stem Cell Transplantation

Prediction Model to Evaluate Engraftment Kinetics Following Stem Cell Transplantation

Fungal Blood Stream Infections (BSI) in Hematology-Oncology Patients Have Worse Outcomes Than Solid Tumour Patients

Tolerability and Clinical Activity of Novel First in Class Oral Agent, Inobrodib (CCS1477), in Combination with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Potent Pre-Clinical and Early Phase Clinical Activity of EP300/CBP Bromodomain Inhibitor CCS1477 in Multiple Myeloma

Use of Cryopreserved Allogeneic PBSC Results in Delayed Engraftment and Increased Incidence of Poor Graft Function

Post Allograft Rituximab Responsive Cytopenia (RRC)

Determinants of Long-Term Survival Following Allogeneic Stem Cell Transplantation for Multiple Myeloma: A Multi-Centre Analysis Across the United Kingdom and Australia

Outcomes with Extracorporeal Photopheresis in the Management of Chronic Gvhd: A Multi-Centre Experience

Seattle Regimen RIC-HSCT in Early-Phase Multiple Myeloma: A Multi-Centre Experience Demonstrating Very Low Treatment-Related Mortality and Rapid Graft-Versus-Myeloma Effect Associated with Graft-Versus-Host Disease

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy and Safety Of Siltuximab, An Anti-Interleukin-6 Monoclonal Antibody, In Patients With Multicentric Castleman’s Disease

Utility of Second and Subsequent Peripheral Blood Stem Cell (PBSC) Mobilization in Myeloma Patients

HCT-CI Does Not Reliably Predict Outcome Following Allogeneic Stem Cell Transplant Due to Poor Correlation Between Clinical and Laboratory Assessment of Comorbidities

The Role of High Dose Chemotherapy and Autologous Stem Cell Transplantation In Patients with Multiple Myeloma Refractory to Initial Induction Therapy

Thyroid Function Abnormalities In Adults Following Haematopoetic Stem Cell Transplant (HSCT).

A Phase 3 Prospective Randomized International Study (MMY-3021) Comparing Subcutaneous and Intravenous Administration of Bortezomib In Patients with Relapsed Multiple Myeloma

Distal Limb Infiltration by Transformed Lymphoplasmacytoid Lymphoma.

Trauma Site Localisation of Extramedullary Plasmacytomata in Thalidomide Treated Myeloma Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only